The Continuing Need for Drug Development and Clinical Trials in Type 2 Diabetes and its Complications: Introduction to The RDS Special Issue

Itamar Raz ,Baptist Gallwitz

Read More

Physiology of Incretins in Health and Disease

Carolyn F. Deacon ,Bo Ahrén

Read More

Incretin Therapy – Present and Future

Alan J. Garber

Read More

The Role of Incretin Therapy at Different Stages of Diabetes

Simona Cernea

Read More

Therapy for Obesity Based on Gastrointestinal Hormones

Jonatan I. Bagger, Mikkel Christensen, Filip K. Knop, Tina Vilsbøll

Read More

SGLT-2 Inhibitors in Development for Type 2 Diabetes Treatment

Mithun Bhartia ,Abd A. Tahrani, Anthony H. Barnett

Read More

Peptides and Their Potential Role in the Treatment of Diabetes and Obesity

Hannah C. Greenwood, Stephen R. Bloom, Kevin G. Murphy

Read More

The Alpha-Cell as Target for Type 2 Diabetes Therapy

Mikkel Christensen, Jonatan I. Bagger, Tina Vilsbøll, Filip K. Knop

Read More

Cardiovascular Effects of Incretin-Based Therapies

Michael Lehrke, Nikolaus Marx

Read More

The Kidney in Type 2 Diabetes Therapy

Hiddo J. Lambers Heerspink, Dick de Zeeuw

Read More

Fatty Heart, Cardiac Damage, and Inflammation

Maria A. Guzzardi, Patricia Iozzo

Read More

GLP-1, the Gut-Brain, and Brain-Periphery Axes

Cendrine Cabou and Rémy Burcelin

Read More

Metabolic Memory and Individual Treatment Aims in Type 2 Diabetes – Outcome-Lessons Learned from Large Clinical Trials

Cristina Bianchi, Stefano Del Prato

Read More